Evaluation of the Espansione Equinox System Safety & Effectiveness for the Treatment of Meibomian Gland Dysfunction.
Open the official record
This page only displays public information reproduced from the official ClinicalTrials.gov record NCT07939360. It adds no medical advice, opinions, or eligibility judgments. The official record remains the source of truth for eligibility criteria, enrollment, and contact information.
All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Evaluation of the Espansione Equinox System Safety & Effectiveness for the Treatment of Meibomian Gland Dysfunction: A Prospective, Multicenter, Randomized Controlled Investigation
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to demonstrate the non-inferiority of the Equinox System with respect to iLux 2020. Approximately 120 participants are expected to take part in the research trial at a minimum of three (3) and up to five (5) sites across the United States. The expected duration of the study will be six (6) months, and subject participation will take approximately four (4) weeks, including three (4) visits; pretreatment visit, Treatment Day, two (2) week follow-up and four (4) week follow-up visits. The investigational therapy in this study is the use of low-level light therapy (LLLT) for the treatment of evaporative dry eye disease due to meibomian gland dysfunction (MGD), when used in conjunction with manual expression of the meibomian glands. Low-Level Light Therapy (LLLT) is a treatment that uses gentle light to help patient cells work better. The light is applied to the skin using special devices. This light can help repair cells that are damaged and improve the function of healthy cells. It may also warm the natural oils in patient eyelids and could reduce tiny mites that sometimes live near the eyelashes. These effects may support overall eye health and comfort. Participants will be randomized to receive treatment using the Equinox System (red mask) or iLux 2020 System ("iLux system"). There is a 50% chance participant will receive treatment with the Equinox System (red mask) and 50% chance participant will receive treatment with the iLux 2020 System. For treatment, participant will be placed in either the prone or supine position. Participant will then wear the red mask for 17 minutes. Special protective eyewear or eye protection is not indicated for this treatment; participant will be instructed to keep eyes closed to ensure full application of the treatment to the upper and lower lids and the periorbital area. Immediately after the treatment is finished, the mask will be removed and the meibomian glands will be manually expressed by a trained and qualified clinician.
Study identification
- NCT ID
- NCT07939360
- Recruitment status
- Active, not recruiting
- Study type
- Interventional
- Phase
- Not applicable
- Enrollment
- 144 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 21 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 12, 2026 (Actual)
- Primary completion
- Dec 31, 2026 (Estimated)
- Completion
- Dec 31, 2026 (Estimated)
- Last update posted
- Nov 16, 2026
2026
United States locations
- U.S. sites
- 7
- U.S. states
- 7
- U.S. cities
- 7
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| MRB Eye Consultants, LLC | Scottsdale | Arizona | 85254 | — |
| East West Eye Institute | Torrance | California | 90505 | — |
| Louisville Eye Center PLLC | Louisville | Kentucky | 40222 | — |
| NothEast Eye Research Associates | Stoneham | Massachusetts | 02180 | — |
| Southern College of Optometry | Medina | Minnesota | 55340 | — |
| Laser Defined Vision | Greensboro | North Carolina | 27401 | — |
| Southern College of Optometry | Memphis | Tennessee | 38104 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT07939360, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 16, 2026 · Synced Nov 16, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.